Managed Care Pharmacist Updates for Proprotein Convertase Subtilisin/kexin type 9 (PCSK9) InhibitorsByJeenal Patel, PharmD, BCGPMarch 12th 2021
Hyperlipidemia: Effective Disease Management With a Focus on PCSK9 InhibitorsByPaul B. Shaw, PharmD, BCPS, BCCPMarch 12th 2021
Guideline Recommendations, Clinical Trial Data, and New and Emerging TherapiesByJohn Lindsley, PharmD, BCPSMarch 12th 2021
